AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
#69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition
Breakpoints
Long Acting Injectables for HIB
The second trial they talked about for treatment was more of a real world setting trial done in San Francisco and this was done in 51 patients in an urban public health HIB clinic. Patients there to be enrolled couldn't have had rope hivering mutations or more than one in a race inhibitor mutation. 24 patients at enrollment were already virologically suppressed and they remain suppressed and undetectable for the whole study period. 15 patients started with detectable by Remia which I think has been an area that people are unsure about with these long acting injectables. 12 of these patients got to an undetectable viral load. Two of those patients have never previously been suppressed ever in more than 10 years of
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode